Exome Asset Management
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- USA
- China
- South Korea
- United Kingdom
- Brazil
- Hong Kong
- Japan
- Taiwan
- Sweden
Investment stages
- Series B
- Series C
Industries
- Health Tech
- Biotechnology
About
Exome Asset Management specializes in identifying and investing in innovative healthcare and biotechnology opportunities across various subsectors globally.
Exome Asset Management specializes in identifying and investing in innovative healthcare and biotechnology opportunities across various subsectors globally.
Investment Thesis
Exome Asset Management focuses on selecting the best and most innovative healthcare investments worldwide. They believe in leveraging rapid technological advances to create compelling investment opportunities across the healthcare sector, including pharmaceuticals, biotechnology, healthcare services, and medical devices.
Manager's Experience
Backed by extensive experience in private equity, the fund manager has actively invested in technology, healthcare, and consumer sectors across North America and Europe. With a track record of over 25 successful deals, they have consistently achieved notable exits, demonstrating a keen ability to identify high-potential opportunities. Their strategic style is rooted in a data-driven approach, focusing on growth-stage companies that exhibit strong fundamentals and scalability. This expertise positions them as a formidable player in the competitive landscape of investment management.
Team
Wongmo Kang
Sameh Ahsan
Sam Isaly
Joseph Narvaez
Christina Maida
Portfolio
Broncus Medical
Centrexion Therapeutics
Impact Therapeutics
New Horizon Health
New Frontier Health